Cite
Role of Antiplatelet Therapy in Hemodialysis Arteriovenous Graft Secondary Patency Following Successful Percutaneous Thrombectomy
MLA
Aaditya Nagaraj, et al. Role of Antiplatelet Therapy in Hemodialysis Arteriovenous Graft Secondary Patency Following Successful Percutaneous Thrombectomy. Dec. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7be5c826c47ee35208347615cccd28ba&authtype=sso&custid=ns315887.
APA
Aaditya Nagaraj, Philip T. Skummer, Vimal Gunasekaran, Christopher Johnson, Allan Roza, Dean Klinger, Sarah White, & Amanda R. Smolock. (2022). Role of Antiplatelet Therapy in Hemodialysis Arteriovenous Graft Secondary Patency Following Successful Percutaneous Thrombectomy.
Chicago
Aaditya Nagaraj, Philip T. Skummer, Vimal Gunasekaran, Christopher Johnson, Allan Roza, Dean Klinger, Sarah White, and Amanda R. Smolock. 2022. “Role of Antiplatelet Therapy in Hemodialysis Arteriovenous Graft Secondary Patency Following Successful Percutaneous Thrombectomy,” December. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7be5c826c47ee35208347615cccd28ba&authtype=sso&custid=ns315887.